Back to search
FDAFDA · Food and drugs·Recall number D-0029-2026

Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01

Published October 22, 2025 · Recall initiated: October 7, 2025

Summary

FDA records drug Class II recall D-0029-2026, published October 22, 2025 and initiated October 7, 2025. Recalling firm: Rising Pharma Holding, Inc.; Status: Ongoing; Reported quantity: 2,064 100-count bottles; Lot: Lot # CS25070, exp. date 03/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).

What to do

Voluntary: Firm initiated · Letter

Get an email if CARBIDOPA, LEVODOPA AND ENTACAPONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CARBIDOPA, LEVODOPA AND ENTACAPONE
Manufacturer
Rising Pharma Holding, Inc.
Distributor
Distributed Nationwide in the USA
UPC
0316571690015
Lot
Lot # CS25070, exp. date 03/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01 recalled?

Yes. FDA published recall D-0029-2026 on October 22, 2025. Reported hazard: Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CARBIDOPA, LEVODOPA AND ENTACAPONE. UPC: 0316571690015.